POC Coagulation Market for 40 Tests: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers--Supplier Shares, Competitive Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review

This new 418-page report contains 42 tables, and provides a comprehensive analysis of the POC coagulation testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
 
Market Segmentation Analysis

- Review of nine POC market segments, including their dynamics, trends, structure,
  size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for coagulation procedures
  by market segment:

- Physician Offices/Group Practices    
- Emergency Rooms       
- Operating/Recovery Suites      
- ICUs/CCUs 
- Cancer Clinics        
- Ambulatory Care Centers        
- Surgery Centers 
- Nursing Homes
- Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major coagulation reagent and instrument suppliers.

Current and Emerging Products

- Analysis of coagulation procedures performed in POC testing locations.
- Review of leading coagulation analyzers, both currently marketed and
  those in development, including their operating characteristics, features and selling prices.

Technology Review

- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing coagulation
   testing technologies and products, by assay.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, joint ventures,
  and new products in R&D.

Strategic Recommendations

- Specific opportunities for new coagulation instruments and reagent systems with potentially
  significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and s proprietary data files.

Introduction
Executive Summary
Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
Worldwide Market and Technology Overview
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Factor VIII
8. Fibrin Degradation Products
9. Fibrinogen
10. Heparin
11. Proteins C and S
12. Prothrombin Time (PT)
13. Thrombin Time

Instrumentation: Coagulation Analyzers Manufactured by:
- Behnk Elektronik
- Bio/Data
- Cardiovascular Diagnostics
- Diagnostica Stago
- Helena Laboratories
- Instrumentation Laboratory
- ITC Hemochron
- Roche
- Siemens
- Sysmex
- Teco Medical Instruments
- Trinity Biotech
Current and Emerging Technologies
1. Monoclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
? Overview
? ELISA
? Dot Immunobinding Assays
? Capillary Immunoassays
? Particle-Membrane Capture Immunoassay
? Enzyme Amplification
c. Fluorescent Immunoassays
? Fluorescent Polarization
? Time-Resolved Pulse Fluorescence
d. Luminescence
? Chemiluminescence
? Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. Dry Chemistry
4. Biosensors
5. IT and Automation
6. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
? Polymerase Chain Reaction

? Ligase Chain Reaction
? Branched DNA
? Q-Beta Replicase
? Strand Displacement Activation
? Self-Sustained Sequence Replicase
U.S.A.
A. Market Overview
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
? PPO
? HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
? More Chronic Illness
? Disease Incidence
? Susceptibility to latrogenesis
? Multiple Illnesses Cases
l. Laboratory Regulations
2. Market Structure
a. Hospitals
b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
1. Market Summary
2. Market Structure
3. Test Volume and Sales Forecasts
C. Ancillary Hospital Locations
1. Introduction
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. Emergency Departments


a. Market Summary
b. Test volume and Sales Forecasts
3. Operating and Recovery Suites
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUs/CCUs
a. Market Summary
b. Test Volume and Sales Forecasts
D. Cancer Clinics
1. Introduction
2. Market Summary
3. Test Volume and Sales Forecasts
E. Ambulatory Care Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
F. Surgery Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
G. Nursing Homes
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
H. Birth Centers
1. Introduction
2. Market Summary
3. Market Structure
4. Test Volume and Sales Forecasts
I. Major Suppliers Instrument Placements,
Installed Base, Consumables Sales and Market Shares

Major Product Development Opportunities
A. Routine and Special Chemistry
B. Microbiology/Infectious Diseases
C. Hematology and Flow Cytometry
D. Coagulation
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
1. Marketing Approaches
2. Product complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Company Profile
- Abbott
- ADI/American Diagnostica
- Alere/Biosite/Inverness
- Axis-Shield
- Beckman Coulter/Danaher


- Becton Dickinson
- Bio/Data Corporation
- Chrono-Log
- Corgenix Medical
- Diagnostica Stago/Trinity Biotech
- Grifols
- Helena Laboratories
- Hyphen BioMed
- Instrumentation Laboratory
- ITC/Nexus Dx
- Roche
- Siemens
- Sienco
- Sysmex
- Thermo Fisher
- ZyCare/Alere

List Of Tables

Major Companies Developing or Marketing
APTT Tests
Major Companies Developing or Marketing
Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing
Antithrombin III Tests
Major Companies Developing or Marketing
Bleeding Time Tests
Major Companies Developing or Marketing
D-Dimer Tests
Major Companies Developing or Marketing
Factor Assays Tests
Major Companies Developing or Marketing
Fibrin Degradation Product Tests
Major Companies Developing or Marketing
Fibrinogen Tests
Major Companies Developing or Marketing
Heparin Tests
Major Companies Developing or Marketing
Protein C Tests
Major Companies Developing or Marketing
Protein S Tests
Major Companies Developing or Marketing
PT Tests
Major Companies Developing or Marketing
Thrombin Time Tests

U.S.A., Physician Office/Group Practice
Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices
Forecast by Type
U.S.A., Office-Based Physicians
Forecast by Practice Type
U.S.A., Physician Offices/Group Practices
Coagulation Test Volume Forecast
U.S.A., Physician Offices/Group Practices
Coagulation Reagent and Instrument Sales Forecast

U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments
Coagulation Test Volume Forecast

U.S.A., Hospital Emergency Departments
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Hospital Operating and Recovery Suites
Coagulation Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Hospital ICUs/CCUs
Coagulation Test Volume Forecast
U.S.A., Hospital ICUs/CCUs
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Cancer Clinics Major
Coagulation Test Volume Forecast
U.S.A., Cancer Clinics
Coagulation Reagent and Instrument Sales Forecast

U.S.A., Ambulatory Care Centers Estimated
Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers
Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers
Coagulation Test Volume Forecast
U.S.A., Ambulatory Care Centers
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Surgery Centers Most
Frequently Performed Procedures
U.S.A., Surgery Centers
Coagulation Test Volume Forecast

U.S.A., Surgery Centers
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Nursing Homes
Estimated Number of Facilities,
Beds and Occupancy Rate
U.S.A., Nursing Homes
Coagulation Test Volume Forecast

U.S.A., Nursing Homes
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Birth Centers Facilities,
Patient Visits, and Births
U.S.A., Birth Centers
Coagulation Test Volume Forecast
U.S.A., Birth Centers
Coagulation Reagent and Instrument Sales Forecast
U.S.A., Major Suppliers of Coagulation
Diagnostic Products Estimated Market Shares

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available